Loading…

High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6

Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhe...

Full description

Saved in:
Bibliographic Details
Published in:Gut 2002-07, Vol.51 (1), p.120-127
Main Authors: Xu, B, Broome, U, Ericzon, B-G, Sumitran-Holgersson, S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3
cites
container_end_page 127
container_issue 1
container_start_page 120
container_title Gut
container_volume 51
creator Xu, B
Broome, U
Ericzon, B-G
Sumitran-Holgersson, S
description Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhesion molecules and production of cytokines. Methods: Sera from patients with various stages of primary sclerosing cholangitis (PSC; n=30), primary biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25), and normal controls (n=12) were investigated for the presence of antibodies that reacted with unstimulated and cytokine stimulated BECs isolated from a normal healthy liver. To demonstrate organ specificity, lung epithelial cells (LECs) were used as control cells. Antibodies were tested for their functional capacity. Results: Compared with controls (8%), significantly higher numbers of PSC patients (63%, p=0.001), but not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies. In 90% of PSC patients, the autoantibodies reacted only with cytokine stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and AIH (0%) patients had LEC antibodies. Other significant findings were that anti-BEC antibodies were found in (i) PSC patients with either the HLA-DRB1*0301 or DR2 allele compared with those without (p=0.007); and (ii) in PBC patients with end stage disease compared with those without (p=0.018). Furthermore, anti-BEC antibodies from PSC and PBC but not AIH patients induced BECs to produce high levels of the cytokine interleukin 6. IgM and IgG fractions isolated from PSC but not PBC and AIH sera induced significantly increased expression of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis of BEC membranes demonstrated a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa bands with PBC sera, which were absent in control groups. Conclusion: Thus for the first time we have demonstrated the presence of functionally important autoantibodies to cell surface expressed antigens on the relevant target cells of destruction, namely BECs, in PSC and PBC. These finding have important implications for the pathogenesis of bile duct destruction in these patients.
doi_str_mv 10.1136/gut.51.1.120
format article
fullrecord <record><control><sourceid>gale_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_593597</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A89076091</galeid><sourcerecordid>A89076091</sourcerecordid><originalsourceid>FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEoqVw44wsIeDCFjsfdnJBqnaBRargQEGIi-U4k6zbrL3YDm1_Fv-QCRu6LAJkKbFmnvl6PUnykNFjxjL-ohviccGO8aT0VnLIcl7OsrQsbyeHlDIxK0ReHST3QjinlJZlxe4mB4gKwWh-mHxfmm5FWg9fB7D6mriWqCE6ZaOpXWMgEGPJRkUDNgZyaeKKbLxZK39Ngu7Bu2BsR_TK9cp2JppA4kpFUhvb4Kc3IwgbDAO890RD3wei0InAoIHA1cZDCMbZsfR8kec_vRvv0B0ns7ERfA_DBfbC7yd3WtUHeDD9j5KPr1-dzZez0_dv3s5PTmc151WcgW5oXZd1U2c5TlsXaauoyhnLW9rwNK051S1jminNtEjbvGk0ytKUDeNNxuvsKJlt84ZL2Ay1nMaWThk5mS7wBrKosqISyIt_8uM4u6BfgazKMiZyjHy5jUT3GhqNUnvV7yfY81izkp37JpkQWSpKTPB0SuAdvmOIcm3CKLWy4IYgBSszkQuO4OM_wHM3eIsyjrmqKk8FH6nnW6pTPUhjW4dVdQcWsLiz0Bo0n5QVFZxWbCfUHo6ngbXRf-On9Bq3J3hobyZlVI4rLXGlZcEknpQi_uh3dXbwtMMIPJkAFbTqW6-sNmHHZSITHB_ppk8TIlzd-JW_kByRQr77NJeLZXH2efHlgxxleLbl6_X5_1v8Aa1dIXU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779942766</pqid></control><display><type>article</type><title>High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6</title><source>PubMed Central</source><creator>Xu, B ; Broome, U ; Ericzon, B-G ; Sumitran-Holgersson, S</creator><creatorcontrib>Xu, B ; Broome, U ; Ericzon, B-G ; Sumitran-Holgersson, S</creatorcontrib><description>Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhesion molecules and production of cytokines. Methods: Sera from patients with various stages of primary sclerosing cholangitis (PSC; n=30), primary biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25), and normal controls (n=12) were investigated for the presence of antibodies that reacted with unstimulated and cytokine stimulated BECs isolated from a normal healthy liver. To demonstrate organ specificity, lung epithelial cells (LECs) were used as control cells. Antibodies were tested for their functional capacity. Results: Compared with controls (8%), significantly higher numbers of PSC patients (63%, p=0.001), but not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies. In 90% of PSC patients, the autoantibodies reacted only with cytokine stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and AIH (0%) patients had LEC antibodies. Other significant findings were that anti-BEC antibodies were found in (i) PSC patients with either the HLA-DRB1*0301 or DR2 allele compared with those without (p=0.007); and (ii) in PBC patients with end stage disease compared with those without (p=0.018). Furthermore, anti-BEC antibodies from PSC and PBC but not AIH patients induced BECs to produce high levels of the cytokine interleukin 6. IgM and IgG fractions isolated from PSC but not PBC and AIH sera induced significantly increased expression of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis of BEC membranes demonstrated a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa bands with PBC sera, which were absent in control groups. Conclusion: Thus for the first time we have demonstrated the presence of functionally important autoantibodies to cell surface expressed antigens on the relevant target cells of destruction, namely BECs, in PSC and PBC. These finding have important implications for the pathogenesis of bile duct destruction in these patients.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>EISSN: 1458-3288</identifier><identifier>DOI: 10.1136/gut.51.1.120</identifier><identifier>PMID: 12077104</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>adhesion molecules ; Adult ; Aged ; AIH ; ALDs ; Antigens ; Autoantibodies ; Autoantibodies - blood ; Autoimmune diseases ; autoimmune hepatitis ; autoimmune liver diseases ; BECs ; Bile Ducts - immunology ; biliary epithelial cells ; Binding sites ; Biological and medical sciences ; Case-Control Studies ; Cell Separation ; Cells, Cultured ; Chi-Square Distribution ; Cholangitis ; Cholangitis, Sclerosing - immunology ; Complement Fixation Tests ; cytokines ; Epithelial Cells - immunology ; Female ; FITC ; fluorescein isothiocynate ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatitis ; Hepatitis, Autoimmune - immunology ; Humans ; Hyaluronan Receptors - immunology ; IFN-γ ; Immunoglobulins ; Inflammatory bowel disease ; interferon γ ; interleukin ; Interleukin-6 - biosynthesis ; Interleukin-6 - immunology ; LECs ; Liver and Biliary Disease ; Liver cirrhosis ; Liver Cirrhosis, Biliary - immunology ; Liver diseases ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; lung epithelial cells ; Male ; Measurement ; Medical sciences ; Medicin och hälsovetenskap ; Middle Aged ; Other diseases. Semiology ; Pathogenesis ; Patients ; PBC ; PBS ; phosphate buffered saline ; Physiological aspects ; primary biliary cirrhosis ; primary sclerosing cholangitis ; Protein Binding ; Proteins ; PSC ; Rodents ; SDS-PAGE ; Smooth muscle ; sodium dodecyl sulphate-polyacrylamide gel electrophoresis ; Statistics, Nonparametric ; TNF-α ; tumour necrosis factor α</subject><ispartof>Gut, 2002-07, Vol.51 (1), p.120-127</ispartof><rights>Copyright 2002 by Gut</rights><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2002 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2002 Copyright 2002 by Gut</rights><rights>Copyright © Copyright 2002 by Gut 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1773278/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1773278/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13737659$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12077104$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1933174$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, B</creatorcontrib><creatorcontrib>Broome, U</creatorcontrib><creatorcontrib>Ericzon, B-G</creatorcontrib><creatorcontrib>Sumitran-Holgersson, S</creatorcontrib><title>High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6</title><title>Gut</title><addtitle>Gut</addtitle><description>Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhesion molecules and production of cytokines. Methods: Sera from patients with various stages of primary sclerosing cholangitis (PSC; n=30), primary biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25), and normal controls (n=12) were investigated for the presence of antibodies that reacted with unstimulated and cytokine stimulated BECs isolated from a normal healthy liver. To demonstrate organ specificity, lung epithelial cells (LECs) were used as control cells. Antibodies were tested for their functional capacity. Results: Compared with controls (8%), significantly higher numbers of PSC patients (63%, p=0.001), but not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies. In 90% of PSC patients, the autoantibodies reacted only with cytokine stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and AIH (0%) patients had LEC antibodies. Other significant findings were that anti-BEC antibodies were found in (i) PSC patients with either the HLA-DRB1*0301 or DR2 allele compared with those without (p=0.007); and (ii) in PBC patients with end stage disease compared with those without (p=0.018). Furthermore, anti-BEC antibodies from PSC and PBC but not AIH patients induced BECs to produce high levels of the cytokine interleukin 6. IgM and IgG fractions isolated from PSC but not PBC and AIH sera induced significantly increased expression of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis of BEC membranes demonstrated a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa bands with PBC sera, which were absent in control groups. Conclusion: Thus for the first time we have demonstrated the presence of functionally important autoantibodies to cell surface expressed antigens on the relevant target cells of destruction, namely BECs, in PSC and PBC. These finding have important implications for the pathogenesis of bile duct destruction in these patients.</description><subject>adhesion molecules</subject><subject>Adult</subject><subject>Aged</subject><subject>AIH</subject><subject>ALDs</subject><subject>Antigens</subject><subject>Autoantibodies</subject><subject>Autoantibodies - blood</subject><subject>Autoimmune diseases</subject><subject>autoimmune hepatitis</subject><subject>autoimmune liver diseases</subject><subject>BECs</subject><subject>Bile Ducts - immunology</subject><subject>biliary epithelial cells</subject><subject>Binding sites</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Cell Separation</subject><subject>Cells, Cultured</subject><subject>Chi-Square Distribution</subject><subject>Cholangitis</subject><subject>Cholangitis, Sclerosing - immunology</subject><subject>Complement Fixation Tests</subject><subject>cytokines</subject><subject>Epithelial Cells - immunology</subject><subject>Female</subject><subject>FITC</subject><subject>fluorescein isothiocynate</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatitis</subject><subject>Hepatitis, Autoimmune - immunology</subject><subject>Humans</subject><subject>Hyaluronan Receptors - immunology</subject><subject>IFN-γ</subject><subject>Immunoglobulins</subject><subject>Inflammatory bowel disease</subject><subject>interferon γ</subject><subject>interleukin</subject><subject>Interleukin-6 - biosynthesis</subject><subject>Interleukin-6 - immunology</subject><subject>LECs</subject><subject>Liver and Biliary Disease</subject><subject>Liver cirrhosis</subject><subject>Liver Cirrhosis, Biliary - immunology</subject><subject>Liver diseases</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>lung epithelial cells</subject><subject>Male</subject><subject>Measurement</subject><subject>Medical sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>PBC</subject><subject>PBS</subject><subject>phosphate buffered saline</subject><subject>Physiological aspects</subject><subject>primary biliary cirrhosis</subject><subject>primary sclerosing cholangitis</subject><subject>Protein Binding</subject><subject>Proteins</subject><subject>PSC</subject><subject>Rodents</subject><subject>SDS-PAGE</subject><subject>Smooth muscle</subject><subject>sodium dodecyl sulphate-polyacrylamide gel electrophoresis</subject><subject>Statistics, Nonparametric</subject><subject>TNF-α</subject><subject>tumour necrosis factor α</subject><issn>0017-5749</issn><issn>1468-3288</issn><issn>1458-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9kk1v1DAQhiMEoqVw44wsIeDCFjsfdnJBqnaBRargQEGIi-U4k6zbrL3YDm1_Fv-QCRu6LAJkKbFmnvl6PUnykNFjxjL-ohviccGO8aT0VnLIcl7OsrQsbyeHlDIxK0ReHST3QjinlJZlxe4mB4gKwWh-mHxfmm5FWg9fB7D6mriWqCE6ZaOpXWMgEGPJRkUDNgZyaeKKbLxZK39Ngu7Bu2BsR_TK9cp2JppA4kpFUhvb4Kc3IwgbDAO890RD3wei0InAoIHA1cZDCMbZsfR8kec_vRvv0B0ns7ERfA_DBfbC7yd3WtUHeDD9j5KPr1-dzZez0_dv3s5PTmc151WcgW5oXZd1U2c5TlsXaauoyhnLW9rwNK051S1jminNtEjbvGk0ytKUDeNNxuvsKJlt84ZL2Ay1nMaWThk5mS7wBrKosqISyIt_8uM4u6BfgazKMiZyjHy5jUT3GhqNUnvV7yfY81izkp37JpkQWSpKTPB0SuAdvmOIcm3CKLWy4IYgBSszkQuO4OM_wHM3eIsyjrmqKk8FH6nnW6pTPUhjW4dVdQcWsLiz0Bo0n5QVFZxWbCfUHo6ngbXRf-On9Bq3J3hobyZlVI4rLXGlZcEknpQi_uh3dXbwtMMIPJkAFbTqW6-sNmHHZSITHB_ppk8TIlzd-JW_kByRQr77NJeLZXH2efHlgxxleLbl6_X5_1v8Aa1dIXU</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>Xu, B</creator><creator>Broome, U</creator><creator>Ericzon, B-G</creator><creator>Sumitran-Holgersson, S</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ</general><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>Copyright 2002 by Gut</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20020701</creationdate><title>High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6</title><author>Xu, B ; Broome, U ; Ericzon, B-G ; Sumitran-Holgersson, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>adhesion molecules</topic><topic>Adult</topic><topic>Aged</topic><topic>AIH</topic><topic>ALDs</topic><topic>Antigens</topic><topic>Autoantibodies</topic><topic>Autoantibodies - blood</topic><topic>Autoimmune diseases</topic><topic>autoimmune hepatitis</topic><topic>autoimmune liver diseases</topic><topic>BECs</topic><topic>Bile Ducts - immunology</topic><topic>biliary epithelial cells</topic><topic>Binding sites</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Cell Separation</topic><topic>Cells, Cultured</topic><topic>Chi-Square Distribution</topic><topic>Cholangitis</topic><topic>Cholangitis, Sclerosing - immunology</topic><topic>Complement Fixation Tests</topic><topic>cytokines</topic><topic>Epithelial Cells - immunology</topic><topic>Female</topic><topic>FITC</topic><topic>fluorescein isothiocynate</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatitis</topic><topic>Hepatitis, Autoimmune - immunology</topic><topic>Humans</topic><topic>Hyaluronan Receptors - immunology</topic><topic>IFN-γ</topic><topic>Immunoglobulins</topic><topic>Inflammatory bowel disease</topic><topic>interferon γ</topic><topic>interleukin</topic><topic>Interleukin-6 - biosynthesis</topic><topic>Interleukin-6 - immunology</topic><topic>LECs</topic><topic>Liver and Biliary Disease</topic><topic>Liver cirrhosis</topic><topic>Liver Cirrhosis, Biliary - immunology</topic><topic>Liver diseases</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>lung epithelial cells</topic><topic>Male</topic><topic>Measurement</topic><topic>Medical sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>PBC</topic><topic>PBS</topic><topic>phosphate buffered saline</topic><topic>Physiological aspects</topic><topic>primary biliary cirrhosis</topic><topic>primary sclerosing cholangitis</topic><topic>Protein Binding</topic><topic>Proteins</topic><topic>PSC</topic><topic>Rodents</topic><topic>SDS-PAGE</topic><topic>Smooth muscle</topic><topic>sodium dodecyl sulphate-polyacrylamide gel electrophoresis</topic><topic>Statistics, Nonparametric</topic><topic>TNF-α</topic><topic>tumour necrosis factor α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, B</creatorcontrib><creatorcontrib>Broome, U</creatorcontrib><creatorcontrib>Ericzon, B-G</creatorcontrib><creatorcontrib>Sumitran-Holgersson, S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, B</au><au>Broome, U</au><au>Ericzon, B-G</au><au>Sumitran-Holgersson, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>2002-07-01</date><risdate>2002</risdate><volume>51</volume><issue>1</issue><spage>120</spage><epage>127</epage><pages>120-127</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><eissn>1458-3288</eissn><coden>GUTTAK</coden><abstract>Aim: Sera of patients with autoimmune liver diseases were investigated for the presence of autoantibodies binding to human biliary epithelial cells (BECs). Furthermore, their functional capacity was investigated by testing their capacity to fix complement as well as induce expression of various adhesion molecules and production of cytokines. Methods: Sera from patients with various stages of primary sclerosing cholangitis (PSC; n=30), primary biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25), and normal controls (n=12) were investigated for the presence of antibodies that reacted with unstimulated and cytokine stimulated BECs isolated from a normal healthy liver. To demonstrate organ specificity, lung epithelial cells (LECs) were used as control cells. Antibodies were tested for their functional capacity. Results: Compared with controls (8%), significantly higher numbers of PSC patients (63%, p=0.001), but not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies. In 90% of PSC patients, the autoantibodies reacted only with cytokine stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and AIH (0%) patients had LEC antibodies. Other significant findings were that anti-BEC antibodies were found in (i) PSC patients with either the HLA-DRB1*0301 or DR2 allele compared with those without (p=0.007); and (ii) in PBC patients with end stage disease compared with those without (p=0.018). Furthermore, anti-BEC antibodies from PSC and PBC but not AIH patients induced BECs to produce high levels of the cytokine interleukin 6. IgM and IgG fractions isolated from PSC but not PBC and AIH sera induced significantly increased expression of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis of BEC membranes demonstrated a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa bands with PBC sera, which were absent in control groups. Conclusion: Thus for the first time we have demonstrated the presence of functionally important autoantibodies to cell surface expressed antigens on the relevant target cells of destruction, namely BECs, in PSC and PBC. These finding have important implications for the pathogenesis of bile duct destruction in these patients.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>12077104</pmid><doi>10.1136/gut.51.1.120</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 2002-07, Vol.51 (1), p.120-127
issn 0017-5749
1468-3288
1458-3288
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_593597
source PubMed Central
subjects adhesion molecules
Adult
Aged
AIH
ALDs
Antigens
Autoantibodies
Autoantibodies - blood
Autoimmune diseases
autoimmune hepatitis
autoimmune liver diseases
BECs
Bile Ducts - immunology
biliary epithelial cells
Binding sites
Biological and medical sciences
Case-Control Studies
Cell Separation
Cells, Cultured
Chi-Square Distribution
Cholangitis
Cholangitis, Sclerosing - immunology
Complement Fixation Tests
cytokines
Epithelial Cells - immunology
Female
FITC
fluorescein isothiocynate
Gastroenterology. Liver. Pancreas. Abdomen
Hepatitis
Hepatitis, Autoimmune - immunology
Humans
Hyaluronan Receptors - immunology
IFN-γ
Immunoglobulins
Inflammatory bowel disease
interferon γ
interleukin
Interleukin-6 - biosynthesis
Interleukin-6 - immunology
LECs
Liver and Biliary Disease
Liver cirrhosis
Liver Cirrhosis, Biliary - immunology
Liver diseases
Liver. Biliary tract. Portal circulation. Exocrine pancreas
lung epithelial cells
Male
Measurement
Medical sciences
Medicin och hälsovetenskap
Middle Aged
Other diseases. Semiology
Pathogenesis
Patients
PBC
PBS
phosphate buffered saline
Physiological aspects
primary biliary cirrhosis
primary sclerosing cholangitis
Protein Binding
Proteins
PSC
Rodents
SDS-PAGE
Smooth muscle
sodium dodecyl sulphate-polyacrylamide gel electrophoresis
Statistics, Nonparametric
TNF-α
tumour necrosis factor α
title High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A40%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20frequency%20of%20autoantibodies%20in%20patients%20with%20primary%20sclerosing%20cholangitis%20that%20bind%20biliary%20epithelial%20cells%20and%20induce%20expression%20of%20CD44%20and%20production%20of%20interleukin%206&rft.jtitle=Gut&rft.au=Xu,%20B&rft.date=2002-07-01&rft.volume=51&rft.issue=1&rft.spage=120&rft.epage=127&rft.pages=120-127&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.51.1.120&rft_dat=%3Cgale_swepu%3EA89076091%3C/gale_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b669t-ecd0bb8bdb34207b52fa0a4114f0d622b60cf11c1ac1c72f4ddc120d8d16d36b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1779942766&rft_id=info:pmid/12077104&rft_galeid=A89076091&rfr_iscdi=true